Duflos, M. | IICIMED

Duflos, M.

Professeur

Publications

P182

Tetrahedron Lett. 2018, 59, 3519-3523.

Novel approach towards 3,7-disubstituted 1,6-naphthyridin-4(1H)-ones exploiting cross-coupling and SNAr reactions of a dihalogenated compound.


doi: 10.1016/j.tetlet.2018.08.013

P168

X-Ray Struct. Anal. Online 2017, 33, 41-43.

Crystal structure of N-(7-{[2-(dimethylamino)ethyl]amino}-1-methyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-3,4,5-trimethoxybenzamide.


doi: 10.2116/xraystruct.33.41

P156

Eur. J. Med. Chem. 2016, 119, 17-33.

Novel 1,6-naphthyridin-2(1H)-ones as potential anticancer agents targeting Hsp90.


doi: 10.1016/j.ejmech.2016.04.050

P141

Tetrahedron 2015, 71, 3303-3313.

Efficient one-pot synthesis of 3,7-disubstituted 1,6-naphthyridin-2(1H)-ones through regioselective palladium-catalyzed cross-coupling and SNAr reactions.


doi: 10.1016/j.tet.2015.03.110

P140

 Mar. Drugs 2015, 13, 4934-48. 

The Marine-Derived Fungus Clonostachys rosea, Source of a Rare Conjugated 4-Me-6E,8E-hexadecadienoic Acid Reducing Viability of MCF-7 Breast Cancer Cells and Gene Expression of Lipogenic Enzymes.


doi: 10.3390/md13084934

P125

Eur. J. Org. Chem. 2014, 7, 1487-1495.

Differential functionalization of 1,6-naphthyridin-2(1H)-ones through sequential one-pot Suzuki-Miyaura cross-couplings.


P114

ACS Med. Chem. Lett., 2013, 4, 288-292.

Discovery of a novel broad-spectrum antifungal agent, derived from albaconazole.


P113

Eur. J. Med. Chem. 2013, 59, 283-295.

Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases.


P112

J. Het. Chem., 2013, 50, 1187-1197.

Efficient new synthesis of N-arylbenzo[b]furo[3,2-d]pyrimidin-4-amines and their benzo[b]thieno[3,2-d]pyrimidin-4-amine analogues via a microwave-assisted Dimroth rearrangement.


P107

Eur. J. Med. Chem., 2012, 58, 171-183.

Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors.


P100

Tetrahedron Lett., 2012, 53, 944-947. 

First synthesis of 4-aminopyrido[2',3':4,5]furo[3,2-d]pyrimidines.


P96

ChemMedChem, 2011, 6, 1806-1815.

Design, synthesis and biological evaluation of 1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as potent antifungal agents: new insights into structure-activity relationships.


P92

Tetrahedron, 2011, 67, 4767-4773.

A convenient route to functionalized 3-amino-N-methylfuro[3,2-b]pyridine-2-carboxamides.


P91

ChemMedChem, 2011, 6, 816-825.

Design, synthesis and in vitro antifungal activity of 1-[(4-substituted benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.


P87

J. Enzym. Inhib. Med. Chem.,  2011, 26(2), 261-269.

Synthesis and in vitro antifungal evaluation of 2-(2,4-difluorophenyl)-1-[(1H-indol-3-ylmethyl)methylamino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.


P86

Bioorg. Med. Chem. Lett., 2010, 20, 5203-5206.

Synthesis of N-aryl-3-(indol-3-yl)propanamides and their immunosuppressive activities.


P84

Tetrahedron, 2010, 66, 4490-4494.

A convenient route to functionalized 3-amino-6-bromofuro[3,2-b]pyridine-2-carboxamides.


P78

J. Pharmacol. Exp. Ther., 2009, 331(2), 710-716.

A novel indole-3-propanamide exerts its immunosuppressive activity by inhibiting JAK3 in T cells.


P75

Tetrahedron Lett., 2009, 50(41), 5729-5732.

A convenient synthesis of 5-arylamino-4H-pyran-4-ones using palladium-catalyzed amination.


P65

J. Enz. Inh. Med. Chem. 2008, 23(5), 629-640. 

Design, synthesis and evaluation of new 6-substituted-5-benzyloxy-4-oxo-4H-pyran-2-carboxamides as potential Src inhibitors.


Autres publications scientifiques

Brevets

B12.

Nouveaux dérivés indoliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.


Brevet Français, déposé le 18 octobre 2006, sous le n° 06/09114.

B11.

Nouveaux dérivés indoliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.


Brevet Français, déposé le 18 octobre 2006, sous le n° 06/09113.

B4.

Nouveaux dérivés de 3-aryl-2,5-dihydroxy-1,4-benzoquinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.


Fr. Pat. n° 02.01409, 06 Feb. 2002.

Thèse